Plantier J C, Damond F, Souquières S, Brun-Vézinet F, Simon F, Barin F
Laboratoire de Virologie, Equipe Associée 2639, Université François Rabelais, Tours, France.
J Clin Microbiol. 2001 Oct;39(10):3803-7. doi: 10.1128/JCM.39.10.3803-3807.2001.
V3 enzyme immunoassays have been shown to discriminate effectively between human immunodeficiency virus type 1 (HIV-1) subtypes. The aim of this study was to investigate the feasibility of V3 serotyping for HIV-2 infection. We serotyped 29 sera with three peptides, corresponding to the V3 loop of subtypes A, B, and D of HIV-2. Sera were collected from HIV-2-infected patients, whose infecting strains were sequenced and subjected to phylogenetic analysis. Our results indicate that HIV-2 serotyping using V3 peptides is not relevant. V3 serotyping data were not consistent with genotyping results. The V3-A and V3-D peptides displayed poor discrimination, and the V3-B peptide was not representative of circulating viruses. Comparison of amino acid sequences and serotype reactivities demonstrated the importance of positions 309 and 314, located on either side of the tip of the V3 loop, in antibody binding.
V3酶免疫测定已被证明能有效区分1型人类免疫缺陷病毒(HIV-1)亚型。本研究的目的是探讨V3血清分型用于HIV-2感染的可行性。我们用三种与HIV-2 A、B和D亚型V3环相对应的肽对29份血清进行了血清分型。血清取自HIV-2感染患者,对其感染毒株进行测序并进行系统发育分析。我们的结果表明,使用V3肽进行HIV-2血清分型并不适用。V3血清分型数据与基因分型结果不一致。V3-A和V3-D肽的区分能力较差,V3-B肽不能代表流行病毒。氨基酸序列和血清型反应性的比较表明,位于V3环顶端两侧的309位和314位在抗体结合中具有重要作用。